ACMSD Antikörper
-
- Target Alle ACMSD Antikörper anzeigen
- ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ACMSD Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human ACMSD
- Isotyp
- IgG
- Top Product
- Discover our top product ACMSD Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.2 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))
- Andere Bezeichnung
- ACMSD (ACMSD Produkte)
- Synonyme
- zgc:162888 antikoerper, ACMSD antikoerper, aminocarboxymuconate semialdehyde decarboxylase antikoerper, aminocarboxymuconate semialdehyde decarboxylase S homeolog antikoerper, amino carboxymuconate semialdehyde decarboxylase antikoerper, ACMSD antikoerper, acmsd antikoerper, acmsd.S antikoerper, Acmsd antikoerper
- Hintergrund
- The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS). ACMSD (ACMS decarboxylase, EC 4.1.1.45) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS.
- Molekulargewicht
- 38 kDa
- UniProt
- Q8TDX5
-